Cynata Therapeutics Limited (ASX:CYP) Reports Positive DFU Trial Results
Cynata Therapeutics (ASX:CYP) reports successful outcomes from its CYP-006TK clinical trial for diabetic foot ulcers, highlighting safety and efficacy.
Cynata Therapeutics (ASX:CYP) reports successful outcomes from its CYP-006TK clinical trial for diabetic foot ulcers, highlighting safety and efficacy.
CLINUVEL’s Chairman reflects on operational achievements and outlines strategic objectives for the upcoming year.
Aumake Limited (ASX: AUK) announces the successful completion of its first trial shipments under a procurement framework with Yangtze River SOE.
Fonterra Co-operative Group Ltd (ASX:FSF) announces a strong Q1 with strategic investments and a focus shift towards high-value sectors.
Rio Tinto announces initial lithium resources and reserves for its Rincon Project in Argentina, with plans for enhanced production capacity.
HeraMED Limited (ASX:HMD) announces key advancements in maternity care through its HeraCARE platform and forming strategic partnerships.
Syntara Limited addresses recent trading activity and plans to present interim data at the ASH Meeting.
Alpha HPA Limited updates on project milestones and market developments across its HPA First Project and product offerings.
Anatara Lifesciences updates on its GaRP-IBS trial with promising recruitment numbers and anticipates results in early 2025.
4DMedical Limited (ASX:4DX) presents its innovative CT:VQ technology at RSNA 2024, poised to revolutionise lung health diagnostics.